Get the Stockscreener App
5.71
5.78%
-0.35
After Hours:
5.69
-0.02
-0.35%
Engene Holdings Inc stock is traded at $5.71, with a volume of 86,050.
It is down -5.78% in the last 24 hours and up +56.87% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$6.06
Open:
$6.06
24h Volume:
86,050
Relative Volume:
0.67
Market Cap:
$291.81M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-1.2413
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+10.23%
1M Performance:
+56.87%
6M Performance:
+7.94%
1Y Performance:
-14.14%
1-Day Range:
$5.5201
$6.54
1-Week Range:
$5.04
$6.54
52-Week Range:
$2.65
$11.00
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
5.71 | 321.45M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
Using fundamentals and technicals on enGene Holdings Inc.Entry Point & Real-Time Buy Signal Alerts - Newser
engene holdings inc. equity warrant stock prediction for this weekJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - Newser
Is enGene Holdings Inc. Equity Warrant meeting your algorithmic filter criteriaJuly 2025 Opening Moves & Low Risk Entry Point Guides - Newser
Combining machine learning predictions for enGene Holdings Inc.Market Rally & Weekly High Return Opportunities - Newser
What MACD and RSI say about enGene Holdings Inc.2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Using RSI to spot recovery in enGene Holdings Inc.Dollar Strength & High Yield Equity Trading Tips - Newser
What institutional flow reveals about enGene Holdings Inc. Equity WarrantMarket Activity Report & Fast Exit Strategy with Risk Control - Newser
enGene Holdings Inc. stock daily chart insightsWeekly Profit Summary & Consistent Return Investment Signals - Newser
enGene Holdings Inc. Equity Warrant stock prediction for this weekWeekly Stock Recap & Low Drawdown Momentum Ideas - Newser
Is enGene Holdings Inc. stock entering bullish territoryLong Setup & Weekly Top Gainers Alerts - Newser
Analyzing drawdowns of enGene Holdings Inc. Equity Warrant with statistical tools2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Published on: 2025-09-12 12:55:28 - Newser
What technical models suggest about enGene Holdings Inc. Equity Warrant’s comebackMarket Risk Summary & Long-Term Capital Growth Ideas - Newser
H.C. Wainwright reiterates buy rating on Engene stock, maintains $25 price target - Investing.com Nigeria
What’s the recovery path for long term holders of enGene Holdings Inc.Entry Point & Risk Managed Investment Signals - Newser
How to read the order book for enGene Holdings Inc.July 2025 Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Market reaction to enGene Holdings Inc. Equity Warrant’s recent newsMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
enGene Holdings Inc. Equity Warrant stock trend forecastQuarterly Portfolio Report & Weekly High Conviction Ideas - Newser
Will a bounce in enGene Holdings Inc. Equity Warrant offer an exitStop Loss & Momentum Based Trading Signals - Newser
How to escape a deep drawdown in enGene Holdings Inc. Equity Warrant2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser
Earnings visualization tools for enGene Holdings Inc. Equity WarrantBull Run & Verified Stock Trade Ideas - Newser
How to recover losses in enGene Holdings Inc. Equity Warrant stockJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - Newser
Using Ichimoku Cloud for enGene Holdings Inc. Equity Warrant technicalsPortfolio Performance Report & Accurate Buy Signal Alerts - Newser
HC Wainwright Has Optimistic Outlook of enGene Q4 Earnings - Defense World
Combining price and volume data for enGene Holdings Inc. Equity WarrantMarket Movers & Daily Volume Surge Trade Alerts - Newser
Multi asset correlation models including enGene Holdings Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
enGene Holdings Reports Q3 2025 Results and Milestones - TipRanks
Will enGene Holdings Inc. Equity Warrant rebound enough to break evenEarnings Recap Summary & High Return Stock Watch Alerts - Newser
enGene Reports Third Quarter 2025 Financial Results and Provides Business Update - PharmiWeb.com
enGene Holdings Inc. (NASDAQ:ENGN) Receives $23.29 Average Price Target from Brokerages - MarketBeat
enGene Holdings Achieves Key Milestone in LEGEND Trial and Secures RMAT Designation - TipRanks
ENGENE HOLDINGS Earnings Results: $ENGN Reports Quarterly Earnings - Quiver Quantitative
How to escape a deep drawdown in enGene Holdings Inc.July 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
Is enGene Holdings Inc. still worth holding after the dipPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser
Is EnGene Holdings (NASDAQ:ENGN) Using Too Much Debt? - 富途牛牛
Should you hold or exit enGene Holdings Inc. Equity Warrant nowWall Street Watch & Risk Managed Investment Signals - Newser
Can technical indicators confirm enGene Holdings Inc. Equity Warrant’s reversalJobs Report & Verified Swing Trading Watchlist - Newser
Transcript : EnGene Holdings Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 01 - MarketScreener
Is enGene Holdings Inc. stock ready for a breakoutEarnings Risk Summary & Real-Time Volume Analysis Alerts - Newser
enGene (NASDAQ:ENGN) Given "Buy" Rating at HC Wainwright - MarketBeat
Chart based analysis of enGene Holdings Inc. Equity Warrant trendsWeekly Trend Report & AI Enhanced Execution Alerts - Newser
Forecasting enGene Holdings Inc. price range with options data2025 Support & Resistance & Technical Confirmation Trade Alerts - Newser
How to manage a losing position in enGene Holdings Inc. Equity WarrantWeekly Stock Report & Weekly Breakout Opportunity Watchlist - Newser
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):